AI

FICS Attest · AI Validation

The AI-native CSA validation platform that replaces spreadsheets and manual testing, for good.

Built for the CSA era

CSA-NativeAI-DrivenAudit-ReadyCI/CD Integrated
GxP Impact Suggestion
FMEA Risk Draft
Test Script Generation (CSA-aligned: focused, not exhaustive)
One-Click Assessment Draft

Inside the product

Validation that assembles its own evidence

FICS Attest workspace showing a risk-based validation package with linked requirements, tests, and audit-ready evidence.

The Problem

Validation is the bottleneck slowing every release

Slow Releases

Validation cycles take 4–6 weeks per release, creating a bottleneck that delays software improvements and trial timelines.

Fragile Manual Processes

CSV-era spreadsheets and manual test cases require hundreds of hours of FTE labor, with high error rates and poor traceability.

Audit Risk

Fragmented documentation across tools and teams means inspection-readiness is never guaranteed, and gaps can surface at the worst moments.

FDA's CSA guidance demands a risk-based, automation-first approach, but most platforms haven't caught up.

CSV vs CSA

A different approach to assurance

Old World: CSV

  • Test everything, document everything
  • Compliance proven through sheer volume
  • High effort, low signal
  • Months-long validation cycles
  • Static documentation, instant obsolescence

New World: CSA

  • Test what matters, risk-based scoping
  • Justify decisions with critical thinking
  • High confidence, right effort
  • Days-long validation cycles
  • Continuous, living documentation

FICS Attest is built from the ground up for CSA, not retrofitted from a CSV-era product. FDA Computer Software Assurance (Final Guidance, September 2025) is the most significant regulatory shift in validation in two decades.

What It Does

What CI/CD did for software deployment, FICS Attest does for GxP validation

Risk-Based Test Scoping

Auto-determines what to test based on GAMP category, system criticality, and change impact, eliminating redundant testing.

CSA-Aligned Documentation

Generates audit-ready validation packages formatted to FDA CSA and GxP expectations, no legacy templates required.

Continuous Validation

Direct interface with applications so validation runs alongside development, not as a downstream bottleneck after release.

Audit Trail & Traceability

Every decision, test, and deviation is auto-traced and auditable. Inspection-ready at any point in the release cycle.

How It Works

From release scope to a submittable validation package

  1. 1

    Define Release Scope

    Work items sync directly from your ticketing system.

  2. 2

    AI Agent Learns the Application

    The agent studies the target application it will validate against.

  3. 3

    GxP Impact Assessment

    AI auto-suggests Yes / No / Indirect for each change.

  4. 4

    Risk Assessment

    AI draft with historical pattern matching across prior releases.

  5. 5

    Validation Approach

    Risk-based testing paired with AI-generated test scripts.

  6. 6

    Auto Traceability

    Requirements linked to tests, automatically (Req ↔ Test).

  7. 7

    Evidence Repository

    All evidence linked to the release and its requirements.

  8. 8

    Validation Package

    Deliverables auto-assembled into a complete, submittable package.

AI Engine, human-in-the-loop

  • GxP Impact Suggestion
  • FMEA Risk Draft
  • Test Script Generation (CSA-aligned: focused, not exhaustive)
  • One-Click Assessment Draft

Plugs In, No Rip-and-Replace

The Validation Brain that plugs into your existing stack

Pulls from

Ticketing

User stories, change tickets, and release scope.

Source Control & CI/CD

Commits, diffs, and build & deploy triggers.

Knowledge & Live Systems

SharePoint, Confluence, and live application behavior.

Exports to

Document Repositories

SharePoint and Veeva Vault.

Other Validation Tools

Legacy VLMS and QMS platforms.

Audit Archives

Inspection-ready evidence packages.

FICS Attest is the Validation Brain that plugs into your existing stack. Supports GAMP Cat. 3, 4 & 5.

Measurable ROI

Real savings, at the scale you already run

Example: a mid-size biotech with 10 validated clinical systems and 3 releases per system per year.

90%

Reduction in validation cycle time (weeks → days)

80%

Reduction in FTE hours per release (150 → 30 hrs)

$1.08M

Annual savings on validation FTEs

$4M+

Estimated total annual value (incl. trial acceleration)

MetricBeforeWith FICS Attest
Avg validation cycle4–6 weeks3–5 days (~36 days saved)
FTE hours per release150 hrs30 hrs
Annual validation FTE cost$1.35M$270K
Audit readinessFragmentedContinuous

Why Now

The moment for CSA-native validation is here

Built by Clinical Researchers

Created by the team behind FICS, used in production trials.

CSA From Day One

Every design decision reflects FDA's CSA final guidance, no CSV legacy.

Strategic IP With Standalone Value

Extensible beyond FICS, for CROs, sponsors, and tech vendors.

Security & Compliance by Design

Full audit trail, role-based access, 21 CFR Part 11-aligned e-signatures, SOC 2-ready.

Ready to leave CSV-era validation behind?

FICS Attest compresses validation cycles from weeks to days, with auditor-ready outputs at every release.

Request a Demo